Mark Kindy to Enzyme-Linked Immunosorbent Assay
This is a "connection" page, showing publications Mark Kindy has written about Enzyme-Linked Immunosorbent Assay.
Connection Strength
0.337
-
Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing A?PP containing the wild-type ?-secretase site sequence. J Alzheimers Dis. 2012; 29(4):827-40.
Score: 0.085
-
Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of A?PP transgenic mice. J Alzheimers Dis. 2011; 25(2):295-307.
Score: 0.080
-
Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse. Brain Res. 2008 Oct 31; 1238:143-53.
Score: 0.068
-
Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine. 2000 Sep; 12(9):1337-47.
Score: 0.039
-
The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2). Mol Immunol. 2017 01; 81:59-66.
Score: 0.030
-
Enzyme-linked immunosorbent assay for an octapeptide based on a genetically engineered fusion protein. Anal Chem. 1993 May 01; 65(9):1147-51.
Score: 0.023
-
Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome. Neurosci Res. 2003 Apr; 45(4):437-45.
Score: 0.012